Trial Profile
An international study of improving treatment for the most severely ill with schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2009
Price :
$35
*
At a glance
- Drugs Risperidone (Primary) ; Clozapine
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms CARE
- 05 Oct 2006 New trial record.